Domača stranPJT • NYSE
add
PJT Partners Inc
142,54 $
Po zaprtju:(0,00 %)0,00
142,54 $
Konec trgovanja: 5. maj, 16:00:46 GMT -4 · USD · NYSE · Izjava
Prejšnji trg. dan.
143,51 $
Dnevni razpon
141,55 $ - 146,21 $
Letni razpon
97,74 $ - 190,28 $
Tržna kapitalizacija
3,48 mrd. USD
Povprečni obseg
343,38 tis.
Razm. P/E
29,06
Dividendna donosnost
0,70 %
Primarna borza
NYSE
V novicah
Finančni podatki
Izkaz poslovnega izida
Prihodek
Čisti dohodek
| (USD) | mar. 2025info | Sprememba L/L |
|---|---|---|
Prihodek | 324,33 mio. | −1,48 % |
Stroški poslovanja | 251,43 mio. | −2,67 % |
Čisti dohodek | 54,02 mio. | 65,58 % |
Čista dobičkovnost prihodkov | 16,65 | 68,01 % |
Earnings per share | 1,05 | 7,14 % |
EBITDA | — | — |
Efektivna davčna stopnja | −41,05 % | — |
Bilanca stanja
Skupna sredstva
Skupne obveznosti
| (USD) | mar. 2025info | Sprememba L/L |
|---|---|---|
Denar. in kratkor. naložbe | 194,27 mio. | −9,86 % |
Skupna sredstva | 1,40 mrd. | 7,29 % |
Skupne obveznosti | 572,39 mio. | 20,85 % |
Celoten lastniški kapital | 824,31 mio. | — |
Shares outstanding | 24,43 mio. | — |
Razmerje P/B | 23,88 | — |
Donosnost sredstev | 19,57 % | — |
Donosnost kapitala | — | — |
Denarni tok
Neto sprememba denarnih sredstev
| (USD) | mar. 2025info | Sprememba L/L |
|---|---|---|
Čisti dohodek | 54,02 mio. | 65,58 % |
Denar iz dejavnosti | −75,94 mio. | −95,83 % |
Denar iz naložb | 28,03 mio. | −53,11 % |
Denar iz financiranja | −245,01 mio. | −54,72 % |
Neto sprememba denarnih sredstev | −289,61 mio. | −106,83 % |
Prost denarni tok | — | — |
Vizitka
PJT Partners, Inc. is a global advisory-focused investment bank, founded in October 2015 as part of The Blackstone Group's spin-off of its financial and strategic advisory services businesses.
PJT operates businesses across strategic advisory, strategic capital markets, restructuring, shareholder advisory and capital raising. The firm has advised on over $1 trillion in M&A transactions including AbbVie's $63 billion acquisition of Allergan, T-Mobile's $59 billion merger with Sprint, and Mylan's $50 billion merger with Pfizer subsidiary, Upjohn.
The firm is headquartered in New York City, with additional offices in Boston, Chicago, Hong Kong, Houston, London, Los Angeles, Madrid, San Francisco and Sydney, and employs approximately 700 people. Wikipedia
Generalni direktor
Datum ustanovitve
2015
Spletno mesto
Zaposleni
1.143
